SpendQueryBeta

Industry · NAICS 541711

Research and Development in Biotechnology

Open notices · Coming up for re-bid · Who wins this work · Typical award sizes

Money by year

  • FY2023$1.89B
  • FY2024$1.07B
  • FY2025$623.38M
  • FY2026$1.06B

Obligations (money committed) in prime awards, from USAspending.gov.

Agencies buying it, FY2025

  1. Department of Energy $894.96M
  2. Department of Homeland Security $40.42M
  3. Department of Defense $2.54M
  4. Department of Transportation -$1
  5. Environmental Protection Agency -$79.7K
  6. Department of Health and Human Services -$314.47M

Offices buying the most, FY2025

  1. Golden Field Office $894.96M
  2. Sci Tech Acq Div $40.42M
  3. National Institutes of Health Nichd $6.04M
  4. Defense Health Agency $3.55M
  5. National Institute of Health Niehs $140.1K
  6. National Institutes of Health $17.6K
  7. National Institutes of Health Ninds $4.0K

Companies winning it, FY2025

  1. Alliance for Energy Innovation, LLC $894.96M
  2. Emergent Biosolutions Inc. $80.00M
  3. Roche Holding Ag $47.50M
  4. Battelle National Biodefense Institute, LLC $40.42M
  5. The Emmes Company, LLC $5.96M
  6. Westat, Inc. $3.47M
  7. American Foundation for Biological Research $1.85M
  8. University of Alabama at Birmingham $1.04M
  9. PPD Development LP $727.2K
  10. Trustees of Tufts College $416.5K

Where the work is, FY2025

  1. Colorado $895.09M
  2. Maryland $96.37M
  3. New Jersey $47.50M
  4. Massachusetts $410.7K
  5. North Carolina $225.7K
  6. Washington $63.0K
  7. Tennessee $21.2K

Contracts ending in the next 12 months

18 contracts, $1.46B with options. The largest:

ContractIncumbentEndsValue with options
75N93019F00131
THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION.
University of Alabama at Birmingham2026-10-31$12.24M
75N93022F00001
CONTRACT HSN272201700036I; UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; SCREENING VACCINE (AND OTHER BIOLOGICS) BASE AWARD; CAN 8470038; TOTAL $563,541.00
University of North Carolina at Chapel Hill2026-11-30$2.25M
HHSO100201600017C
IGF::OT::IGF - DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES)
Dnae Group Holdings Limited2026-12-31$61.91M
W81XWH15C0048
IGF::OT::IGF REGULATORY/PROGRAM MGT/ADMIN SUPPORT
Westat, Inc.2026-12-31$28.60M
HHSN27500007
IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIALCONTRACT # HHSN275201300024I/HHSN27500007
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center2026-12-31$12.02M
75N93024F00002
MODEL DEVELOPMENT AND MEDICAL COUNTER MEASURES (MCMS) FOR BSL-4 AGENTS IN NHPS.
University of Texas Medical Branch at Galveston2027-01-17$6.74M
70RSAT25FR0000019
TO AWARD AND FULLY FUND THE NBACC ANALYTIC TASKS FOR FACILITY SUBCONTRACTED SUPPORT AND NECESSARY UPGRADES, MODIFICATIONS, AND REPAIRS FOR 2025 (THE NBACC II EXTENSION).
Battelle National Biodefense Institute, LLC2027-02-28$3.47M
W911QY13C0056
PROGRAM REPORTING - TECHNICAL
Dynport Vaccine Company LLC2027-03-11$258.06M
70RSAT26FR0000002
NEW FFRDC NBACC 2026 INSURANCE
Battelle National Biodefense Institute, LLC2027-03-18$2.56M
HHSO100201600009C
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
Cerus Corporation2027-03-31$282.17M

All of them, with filters →

Open notices

None open right now. Set an alert for the next one.

From USAspending.gov prime awards and SAM.gov notices. Sources and limits